WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005105079) NOVEL IMIDAZOLES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/105079    International Application No.:    PCT/US2005/012255
Publication Date: 10.11.2005 International Filing Date: 12.04.2005
Chapter 2 Demand Filed:    20.01.2006    
IPC:
A61K 31/4172 (2006.01), A61K 31/4178 (2006.01), C07D 233/70 (2006.01)
Applicants: BOLTON, Gary, Louis [US/US]; (US) (For US Only).
BOWLES, Daniel, Merritt [US/US]; (US) (For US Only).
BOYLES, David, Christopher [US/US]; (US) (For US Only).
HOWARD, JR., Walter, Allen [US/US]; (US) (For US Only).
HUTCHINGS, Richard, Henry [US/US]; (US) (For US Only).
KENNEDY, Robert, Michael [US/US]; (US) (For US Only).
PARK, William, Keun-Chan [CA/US]; (CA) (For US Only).
SONG, Yuntao [US/US]; (US) (For US Only).
TRIVEDI, Bharat, Kalidas [US/US]; (US) (For US Only).
WARNER-LAMBERT COMPANY LLC [US/US]; 201 Tabor Road, Morris Plains, NJ 07950 (US) (For All Designated States Except US)
Inventors: BOLTON, Gary, Louis; (US).
BOWLES, Daniel, Merritt; (US).
BOYLES, David, Christopher; (US).
HOWARD, JR., Walter, Allen; (US).
HUTCHINGS, Richard, Henry; (US).
KENNEDY, Robert, Michael; (US).
PARK, William, Keun-Chan; (CA).
SONG, Yuntao; (US).
TRIVEDI, Bharat, Kalidas; (US)
Agent: FULLER, Grover, F., Jr.; Pfizer Inc., 201 Tabor Road, Morris Plains, NJ 07950 (US)
Priority Data:
60/563,124 16.04.2004 US
60/600,705 11.08.2004 US
Title (EN) NOVEL IMIDAZOLES
(FR) NOUVEAUX IMIDAZOLES
Abstract: front page image
(EN)Novel imidazoles are provided. The compounds are useful as HMGCo-A Reductase Inhibitor. Also provided are pharmaceutical compositions of the compounds. Methods of making and methods of using the compounds are also provided.
(FR)Il est fourni de nouveaux imidazoles. Les composés sont utiles comme inhibiteurs de l'HMGCo-A réductase. Il est également fourni des compositions pharmaceutiques des composés. Il est également fourni des procédés de fabrication et des procédés d'utilisation des composés.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)